TY - JOUR AU - Ariza-Solé, A. AU - Mateus-Porta, G. AU - Formiga, F. AU - Garcia-Blas, S. AU - Bonanad, C. AU - Núñez-Gil, I. AU - Vergara-Uzcategui, C. AU - Díez-Villanueva, P. AU - Bañeras, J. AU - Badia-Molins, C. AU - Aboal, J. AU - Carreras-Mora, J. AU - Gabaldón-Pérez, A. AU - Parada Barcia, Jose Antonio AU - Martínez-Sellés, M. AU - Comín-Colet, J. AU - Raposeiras Roubín, Sergio PY - 2023 SN - 1477-9560 UR - http://hdl.handle.net/20.500.11940/21484 AB - Background: Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data exist about the... LA - eng TI - Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study DO - 10.1186/s12959-023-00476-5 T2 - Thrombosis Journal KW - AS Vigo KW - CHUVI KW - AS Vigo KW - CHUVI VL - 21 ER -